Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review

Cefiderocol Treatment for Severe Infections due to Difficult-to-Treat-Resistant Non-Fermentative Gram-Negative Bacilli in ICU Patients: A Case Series and Narrative Literature Review

Cefiderocol (FDC) is a siderophore cephalosporin now recognized as a new weapon in the treatment of difficult-to-treat-resistant (DTR) Gram-negative pathogens, including carbapenemase-producing enterobacterales and non-fermentative Gram-negative bacilli (GNB). This article reports our experience wit...

Full description

Bibliographic Details
Main Authors: Paul-Henri Wicky, Joséphine Poiraud, Manuel Alves, Juliette Patrier, Camille d’Humières, Minh Lê, Laura Kramer, Étienne de Montmollin, Laurent Massias, Laurence Armand-Lefèvre, Jean-François Timsit
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Antibiotics
Subjects:
cefiderocol
difficult-to-treat organisms
<i>Pseudomonas aeruginosa</i>
<i>Acinetobacter baumannii</i>
<i>Stenotrophomonas maltophilia</i>
critically ill
Online Access:https://www.mdpi.com/2079-6382/12/6/991

Internet

https://www.mdpi.com/2079-6382/12/6/991

Similar Items